Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017

Details for Mechanism ID: 17762
Country/Region: Dominican Republic
Year: 2016
Main Partner: FHI 360
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $1,418,747 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $130,043
Testing: HIV Testing and Counseling (HVCT) $457,103
Sexual Prevention: Other Sexual Prevention (HVOP) $200,000
Treatment: Adult Treatment (HTXS) $631,601
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: 20-24 Female 2017 5
GEND_GBV Age/Sex: 25-49 Female 2017 4
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 9
GEND_GBV Number of people receiving post-GBV care 2017 9
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 3,714
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 3,715
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 7,429
HTS_TST Service Delivery Point (Facility): Other PITC 2017 7,429
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 7,429
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 7,429
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 196
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 200
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 203
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 203
TB_SCREENDX Screen Result: Screened Positive for TB 2017 224
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 1,115
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 1,119
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 2,234
TX_CURR Aggregated Age/Sex: 15+ Female 2017 1,240
TX_CURR Aggregated Age/Sex: 15+ Male 2017 1,243
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 2,483
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 2,483
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 2,483
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 480
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 486
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 966
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 966
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 1,986
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 1,589
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 792
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 797
TX_PVLS Numerator: Indication: Routine 2017 1,589
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 990
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 996
TX_PVLS_den Denominator: Indication: Routine 2017 1,986
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 643
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 644
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,287
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,515
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 757
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 758
Cross Cutting Budget Categories and Known Amounts Total: $1,150,000
Key Populations: MSM and TG $400,000
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Gender: Gender Based Violence (GBV) $350,000
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Key Populations: Sex Workers $400,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Monitoring and evaluation of SW programs